All products / DC23173
YHO-13351
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $500 USDRequest a quote / confirm availability → |
| 250 mg | $1,000 USDRequest a quote / confirm availability → |
| 1 g | $2,000 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo; YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration, significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC23173 |
|---|---|
| Product name | YHO-13351 |
| CAS | 1346753-00-1 |
| Molecular formula | C27H37N3O7S2 |
| Molecular weight | 579.7286 |
| Purity | >98% |
| SMILES | CCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3ccc(OC)c(OC)c3)s2)CC1.CS(=O)(=O)O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — YHO-13351 (DC23173)